Patents by Inventor Marc Verleye

Marc Verleye has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • for the treatment of mood disorders
    Patent number: 11872257
    Abstract: The present invention relates to Saccharomyces boulardii yeast cells, for use in the prevention or treatment of mood disorders, in a person.
    Type: Grant
    Filed: August 10, 2018
    Date of Patent: January 16, 2024
    Assignee: BIOCODEX
    Inventors: Emmanuelle Simon O'Brien, Marc Verleye, Marie-Emmanuelle Le Guern
  • PHARMACEUTICAL COMPOSITION USEFUL FOR PROMOTING OSTEOBLASTOGENESIS
    Publication number: 20230277611
    Abstract: A pharmaceutical composition for promoting osteoblastogenesis, in particular a yeast cell derived product for use for promoting osteoblastogenesis in an individual. The yeast cell-derived product may be derived from yeast cells of the genus Saccharomyces and from yeast cells of the species Saccharomyces boulardii.
    Type: Application
    Filed: September 2, 2021
    Publication date: September 7, 2023
    Applicant: BIOCODEX
    Inventors: Marie-Emmanuelle LE GUERN, Marc VERLEYE
  • Pharmacological treatment of obsessive-compulsive disorder
    Patent number: 10696647
    Abstract: The present invention relates to a compound of the following formula (I): or a pharmaceutically acceptable salt thereof, for use in the prevention or treatment of obsessions and/or compulsions in an individual.
    Type: Grant
    Filed: November 20, 2014
    Date of Patent: June 30, 2020
    Assignee: BIOCODEX
    Inventors: Marc Verleye, Marie-Emmanuelle Le Guern
  • SACCHAROMYCES BOULARDII FOR THE TREATMENT OF MOOD DISORDERS
    Publication number: 20200179469
    Abstract: The present invention relates to Saccharomyces boulardii yeast cells, for use in the prevention or treatment of mood disorders, in a person.
    Type: Application
    Filed: August 10, 2018
    Publication date: June 11, 2020
    Inventors: Emmanuelle SIMON O'BRIEN, Marc VERLEYE, Marie-Emmanuelle LE GUERN
  • TREATMENT OF DISEASES ASSOCIATED WITH A DYSREGULATION OF THE mTOR PATHWAY
    Publication number: 20200179335
    Abstract: The present invention relates to a compound of the following formula (I): or a pharmaceutically acceptable salt, hydrate or solvate thereof, for use in the prevention or treatment of a disease associated with a dysregulation of the mTOR pathway in an individual.
    Type: Application
    Filed: May 30, 2018
    Publication date: June 11, 2020
    Inventors: Véronique RIBAN, Marc VERLEYE, Marie-Emmanuelle LE GUERN
  • COMPOSITION USEFUL FOR THE PREPARATION OF A SUPPOSITORY
    Publication number: 20190142745
    Abstract: The present invention relates to a composition comprising a mixture of Saccharomyces boulardii cells and of a wax.
    Type: Application
    Filed: April 27, 2017
    Publication date: May 16, 2019
    Inventors: Anne BENOIST, Emilie FARGIER, Marie-Emmanuelle LE GUERN, Marc VERLEYE, Patrice TEWA, Xavier ZEISSER
  • Treatment of prolonged status epilepticus
    Patent number: 10183008
    Abstract: Methods for terminating, preventing, and/or treating status epilepticus are generally provided. The method can include administering a prophylactically or therapeutically effective amount of stiripentol or a related compound thereof to an individual in need of treatment of status epilepticus. The individual can be in need of treatment of prolonged status epilepticus, refractory status epilepticus, and/or benzodiazepine-resistant status epilepticus.
    Type: Grant
    Filed: September 19, 2012
    Date of Patent: January 22, 2019
    Assignee: University of South Carolina
    Inventors: David D. Mott, Janet L. Fisher, Rene H. Levy, Marie-Emmanuelle LeGuern, Marc Verleye, Bernard Hublot
  • Treatment of degenerations and light-induced damage to the retina
    Patent number: 9872858
    Abstract: The present invention relates to a compound of the following formula (I): or a pharmaceutically acceptable salt thereof, to be used in the prevention or treatment of light-induced damage and/or a degeneration of the retina in a patient.
    Type: Grant
    Filed: January 28, 2015
    Date of Patent: January 23, 2018
    Assignee: BIOCODEX
    Inventors: Marc Verleye, Philippe Girard, Marie-Emmanuelle Le Guern
  • TREATMENT OF DEGENERATIONS AND LIGHT-INDUCED DAMAGE TO THE RETINA
    Publication number: 20170000798
    Abstract: The present invention relates to a compound of the following formula (I): or a pharmaceutically acceptable salt thereof, to be used in the prevention or treatment of light-induced damage and/or a degeneration of the retina in a patient.
    Type: Application
    Filed: January 28, 2015
    Publication date: January 5, 2017
    Inventors: Marc VERLEYE, Philippe GIRARD, Marie-Emmanuelle LE GUERN
  • PHARMACOLOGICAL TREATMENT OF ATTENTION DEFICIT AND/OR HYPERACTIVITY
    Publication number: 20160331723
    Abstract: The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof, for use in the prevention or treatment of attention deficit and/or hyperactivity in an individual.
    Type: Application
    Filed: December 17, 2014
    Publication date: November 17, 2016
    Inventors: Marc VERLEYE, Véronique RIBAN, Marie-Emmanuelle LE GUERN
  • PHARMACOLOGICAL TREATMENT OF OBSESSIVE-COMPULSIVE DISORDER
    Publication number: 20160289205
    Abstract: The present invention relates to a compound of the following formula (I): or a pharmaceutically acceptable salt thereof, for use in the prevention or treatment of obsessions and/or compulsions in an individual.
    Type: Application
    Filed: November 20, 2014
    Publication date: October 6, 2016
    Inventors: Marc VERLEYE, Marie-Emmanuelle LE GUERN
  • PHARMACEUTICAL COMPOSITION FOR REDUCING BODY FAT
    Publication number: 20160287649
    Abstract: The present invention relates to a pharmaceutical composition comprising, as active substance, Saccharomyces boulardii yeast cells, for use for reducing body fat in an individual.
    Type: Application
    Filed: November 7, 2014
    Publication date: October 6, 2016
    Inventors: Patrice D. CANI, Amandine EVERARD, Lucie GEURTS, Emilie FARGIER, Marc VERLEYE, Marie-Emmanuelle LE GUERN
  • Medicinal product for treating gastrointestinal ulcers
    Patent number: 9241961
    Abstract: The present invention relates to yeast cells for use in the prevention or treatment of gastric or intestinal ulcers.
    Type: Grant
    Filed: December 7, 2010
    Date of Patent: January 26, 2016
    Assignee: BIOCEDEX
    Inventors: Philippe Girard, Marie-Emmanuelle Le Guern, Marc Verleye, Bernard Hublot
  • Compound for use in the treatment of peripheral neuropathies
    Patent number: 8927600
    Abstract: The present invention relates to a compound of the following formula (I): or a pharmaceutically acceptable salt thereof, for use in the prevention or treatment of peripheral neuropathies.
    Type: Grant
    Filed: March 18, 2010
    Date of Patent: January 6, 2015
    Assignee: Biocodex
    Inventors: Marie-Emmanuelle Le Guern, Marc Verleye, Jean-Marie Gillardin, Bernard Hublot
  • Neuroprotective compounds and pharmaceutical compositions comprising them
    Patent number: 8338410
    Abstract: This invention relates to the use of at least one compound of the following formula (I): or its pharmaceutically acceptable salts, for the preparation of a medicinal compound having neuroprotective activity intended to prevent or treat neurone deteriorations.
    Type: Grant
    Filed: July 18, 2006
    Date of Patent: December 25, 2012
    Assignee: Biocodex
    Inventors: Marc Verleye, Marie-Emmanuelle Le Guern, Philippe Girard, Jean-Marie Gillardin, Laurence Berthon-Cedille, Bernard Hublot
  • Medicinal Product for Treating Gastrointestinal Ulcers
    Publication number: 20110135616
    Abstract: The present invention relates to yeast cells for use in the prevention or treatment of gastric or intestinal ulcers.
    Type: Application
    Filed: December 7, 2010
    Publication date: June 9, 2011
    Inventors: Philippe GIRARD, Marie-Emmanuelle Le Guern, Marc Verleye, Bernard Hublot
  • COMPOUND FOR USE IN THE TREATMENT OF PERIPHERAL NEUROPATHIES
    Publication number: 20100240588
    Abstract: The present invention relates to a compound of the following formula (I): or a pharmaceutically acceptable salt thereof, for use in the prevention or treatment of peripheral neuropathies.
    Type: Application
    Filed: March 18, 2010
    Publication date: September 23, 2010
    Inventors: Marie-Emmanuelle LE GUERN, Marc Verleye, Jean-Marie Gillardin, Bernard Hublot
  • ANTI-AMNESIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM
    Publication number: 20090298817
    Abstract: The present invention relates to the use of at least one compound of formula (I) as follows: or of at least one pharmaceutically acceptable salt thereof for the preparation of a drug for the prevention or treatment of memory disorders.
    Type: Application
    Filed: May 6, 2009
    Publication date: December 3, 2009
    Inventors: Marc Verleye, Marie-Emmanuelle Le Guern, Jean-Marie Gillardin, Bernard Hublot
  • Neuroprotective compounds and pharmaceutical compositions comprising them
    Publication number: 20070167446
    Abstract: This invention relates to the use of at least one compound of the following formula (I): or its pharmaceutically acceptable salts, for the preparation of a medicinal compound having neuroprotective activity intended to prevent or treat neurone deteriorations.
    Type: Application
    Filed: July 18, 2006
    Publication date: July 19, 2007
    Inventors: Marc Verleye, Marie-Emmanuelle Le Guern, Philippe Girard, Jean-Marie Gillardin, Laurence Berthon-Cedille, Bernard Hublot